Retroviral vectors are used widely in research and are also being designed
for use in gene therapy trials. In practice, these vectors usually contain
a marker gene, which is often a drug selection gene. In this report, a nove
l retroviral vector has been constructed which contains a gene that allows
selection for infected cells by a magnet. This gene is a single-chain antib
ody (sFv) to a specific hapten molecule 4-ethoxymethylene-2-phenyl-2-uxazol
in-5-one (phOx). sFv specific for phOx is: displayed on the surface of infe
cted cells. This feature allows binding to phOx-BSA coated magnetic beads w
hich are used to isolate the infected cells. (C) 2001 Elsevier Science B.V.
All rights: reserved.